Is Valneva SE halal to invest in?

According to Musaffa's Shariah screening methodology, Valneva SE (VLA.PA) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Valneva SE a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Valneva SE using these criteria to determine its compliance status.

Can Muslims buy shares of Valneva SE?

Muslim investors may consider investing in Valneva SE if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Valneva SE classified as NOT HALAL?

Musaffa determines the Shariah status of Valneva SE by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Valneva SE updated?

The Shariah compliance status of Valneva SE may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Valneva SE become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Valneva SE?

You can check the latest Shariah compliance status of Valneva SE on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Valneva SE VLA.PA

€2.52 €0.03 (1.07%) 1D

Last Updated: May 15, 12:00 AM·XPAR

VLA.PA Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 27, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Valneva SE (VLA.PA)

Based on 11 analysts giving stock ratings to Valneva SE in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valneva SE. Stock Analysis VLA.PA

France Health Care Small Cap Report: 2025 Annual

Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. The company is headquartered in Saint-Herblain, Pays De La Loire and currently employs 694 full-time employees. The company went IPO on 2007-06-28. The firm's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli (ETEC). The firm has also vaccines in development, including candidates against Lyme disease, COVID-19 and chikungunya. Its technologies and services segment cooperates with various pharmaceutical companies using its platform: EB66 vaccine production cell line and IC31 adjuvant. The firm is focused on research and development (R&D) programs, as well as holds investment in product candidates and commercial products.

Key Statistics of Valneva SE (VLA.PA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€2.47€2.60

Today's Open

€2.55

Volume

676.70K

P/E Ratio (TTM)

52 Week Range

€2.14€5.42

Market Cap

388.06M

Avg. Volume

717.99K

Dividend Yield

Financial Metrics & Statements of Valneva SE (VLA.PA)

FAQ's for Valneva SE (VLA.PA)

According to Musaffa’s Shariah screening methodology, Valneva SE (VLA.PA) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.